Cargando…

A Case of Cerebral Venous Sinus Thrombosis Presenting During Relapse of Ulcerative Colitis

Patient: Male, 27 Final Diagnosis: Cerebral venous sinus thrombosis Symptoms: Headache • seizure • weakness Medication: — Clinical Procedure: — Specialty: Gastroenterology and Hepatology OBJECTIVE: Rare disease BACKGROUND: Extra-intestinal manifestations of inflammatory bowel disease (IBD) include t...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdalla, Abubaker O., Alluri, Deepti, Hassaballa, Mohamed, Calvo, Lisa, Otaki, Fouad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454583/
https://www.ncbi.nlm.nih.gov/pubmed/30928992
http://dx.doi.org/10.12659/AJCR.913429
Descripción
Sumario:Patient: Male, 27 Final Diagnosis: Cerebral venous sinus thrombosis Symptoms: Headache • seizure • weakness Medication: — Clinical Procedure: — Specialty: Gastroenterology and Hepatology OBJECTIVE: Rare disease BACKGROUND: Extra-intestinal manifestations of inflammatory bowel disease (IBD) include thromboembolic events that can present as deep vein thrombosis, pulmonary embolism, and cerebral venous sinus thrombosis. Cerebral venous sinus thrombosis is a rare complication of IBD that can be associated with high morbidity and mortality. This report is of a case of cerebral venous sinus thrombosis presenting in a young man during a relapse of ulcerative colitis (UC). CASE REPORT: A 27-year-old man presented with seizures and focal neurological deficit during a relapse of chronic UC. He was found to have left cerebral venous sinus thrombosis complicated by left frontotemporal infarction that was treated with anticoagulation therapy. CONCLUSIONS: Thromboembolic events are well documented extra-intestinal manifestation of IBD. Cerebral venous sinus thrombosis is a rare but serious complication that can be fatal. The correct diagnosis and timely management require a high degree of suspicion in patients with IBD who present with a new-onset headache, focal neurological symptoms, seizure, or altered mental status.